Ameritas Investment Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.64M Sell
14,909
-1,110
-7% -$494K 0.21% 66
2025
Q1
$7.77M Buy
16,019
+117
+0.7% +$56.7K 0.27% 55
2024
Q4
$6.4M Buy
15,902
+162
+1% +$65.2K 0.21% 62
2024
Q3
$7.32M Sell
15,740
-706
-4% -$328K 0.24% 56
2024
Q2
$7.71M Sell
16,446
-63
-0.4% -$29.5K 0.26% 48
2024
Q1
$6.9M Sell
16,509
-106
-0.6% -$44.3K 0.24% 56
2023
Q4
$6.76M Sell
16,615
-88
-0.5% -$35.8K 0.25% 53
2023
Q3
$5.81M Buy
16,703
+856
+5% +$298K 0.23% 57
2023
Q2
$5.58M Sell
15,847
-671
-4% -$236K 0.21% 68
2023
Q1
$5.2M Buy
16,518
+26
+0.2% +$8.19K 0.21% 73
2022
Q4
$4.96M Sell
16,492
-583
-3% -$175K 0.2% 81
2022
Q3
$4.94M Sell
17,075
-229
-1% -$66.3K 0.22% 70
2022
Q2
$4.87M Sell
17,304
-2
-0% -$563 0.21% 73
2022
Q1
$4.52M Sell
17,306
-151
-0.9% -$39.4K 0.16% 101
2021
Q4
$3.83M Sell
17,457
-252
-1% -$55.3K 0.13% 138
2021
Q3
$3.21M Buy
17,709
+161
+0.9% +$29.2K 0.12% 155
2021
Q2
$3.54M Sell
17,548
-76
-0.4% -$15.3K 0.13% 139
2021
Q1
$3.9M Sell
17,624
-64
-0.4% -$14.2K 0.15% 112
2020
Q4
$4.18M Sell
17,688
-142
-0.8% -$33.5K 0.19% 84
2020
Q3
$4.85M Sell
17,830
-411
-2% -$112K 0.22% 67
2020
Q2
$5.3M Sell
18,241
-8
-0% -$2.32K 0.25% 58
2020
Q1
$4.34M Sell
18,249
-1,449
-7% -$345K 0.25% 66
2019
Q4
$4.31M Buy
19,698
+2,559
+15% +$560K 0.19% 74
2019
Q3
$2.9M Buy
17,139
+7,849
+84% +$1.33M 0.13% 144
2019
Q2
$1.7M Sell
9,290
-63
-0.7% -$11.5K 0.08% 286
2019
Q1
$1.72M Buy
9,353
+108
+1% +$19.9K 0.08% 278
2018
Q4
$1.53M Buy
9,245
+67
+0.7% +$11.1K 0.08% 282
2018
Q3
$1.77M Sell
9,178
-265
-3% -$51K 0.08% 294
2018
Q2
$1.6M Sell
9,443
-347
-4% -$58.9K 0.08% 320
2018
Q1
$1.6M Sell
9,790
-296
-3% -$48.3K 0.08% 330
2017
Q4
$1.51M Sell
10,086
-78
-0.8% -$11.7K 0.07% 369
2017
Q3
$1.63M Hold
10,164
0.08% 319
2017
Q2
$1.31M Hold
10,164
0.06% 408
2017
Q1
$1.11M Sell
10,164
-208
-2% -$22.7K 0.06% 471
2016
Q4
$764K Hold
10,372
0.04% 618
2016
Q3
$905K Buy
10,372
+1,117
+12% +$97.5K 0.05% 529
2016
Q2
$796K Buy
9,255
+499
+6% +$42.9K 0.05% 384
2016
Q1
$696K Buy
8,756
+58
+0.7% +$4.61K 0.05% 432
2015
Q4
$1.09M Buy
8,698
+78
+0.9% +$9.81K 0.07% 267
2015
Q3
$898K Buy
8,620
+78
+0.9% +$8.13K 0.06% 305
2015
Q2
$1.06M Buy
8,542
+78
+0.9% +$9.63K 0.07% 287
2015
Q1
$998K Sell
8,464
-7,171
-46% -$846K 0.07% 304
2014
Q4
$1.86M Buy
15,635
+272
+2% +$32.3K 0.13% 172
2014
Q3
$1.73M Sell
15,363
-612
-4% -$68.7K 0.12% 192
2014
Q2
$1.51M Sell
15,975
-355
-2% -$33.6K 0.11% 214
2014
Q1
$1.16M Sell
16,330
-227
-1% -$16.1K 0.09% 258
2013
Q4
$1.23M Buy
16,557
+4,529
+38% +$336K 0.1% 248
2013
Q3
$912K Buy
12,028
+3,528
+42% +$268K 0.09% 290
2013
Q2
$681K Buy
+8,500
New +$681K 0.19% 197